Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Schizophr Res. 2015 Jul 23;168(0):74–78. doi: 10.1016/j.schres.2015.07.014

Premorbid Multivariate Prediction of Adult Psychosis-Spectrum Disorder: A High-Risk Prospective Investigation

Jason Schiffman a, Emily Kline b, Nicole Jameson a, Holger J Sorensen c,d, Shana Dodge e, Thomas Tsuji a, Erik L Mortensen d,f, Sarnoff Mednick f,g
PMCID: PMC4591206  NIHMSID: NIHMS710858  PMID: 26213343

Abstract

Premorbid prediction of psychosis-spectrum disorders has implications for both understanding etiology and clinical identification. The current study used a longitudinal high-risk for psychosis design that included children of parents with schizophrenia as well as two groups of controls (children whose parents had no mental illness, and children with at least one parent with a non-psychotic psychiatric diagnosis). Premorbid neurological factors and an indication of social function, as measured when participants were 10–13 years of age, were combined to predict psychosis-spectrum disorders in adulthood. Through a combination of childhood predictors, the model correctly classified 82% (27 of 33) of the participants who eventually developed a psychosis-spectrum outcome in adulthood. With replication, multivariate premorbid prediction, including genetic risk, social, and neurological variables, could potentially be a useful complementary approach to identifying individuals at risk for developing psychosis-spectrum disorders.

Keywords: psychosis, premorbid, high-risk, neurological, social, prediction

Introduction

Research suggests that neurodevelopmental markers of psychosis are identifiable premorbidly during childhood despite clinical presentation emerging later in life (Walker et al., 2010; Koutsouleris et al., 2015). Previous research that has combined premorbid neurodevelopmental indicators with genetic risk in an effort to predict psychosis has met with mixed success (Erlenmeyer-Kimling et al., 2000; Isohanni et al., 2005). Using prospective data collected by Mednick and colleagues over nearly 50 years, we (Golembo-Smith et al., 2012) identified multiple neurodevelopmental markers as premorbid indicators of risk for a psychosis-spectrum disorder. In this analysis, minor physical anomalies, and at a trend level coordination, laterality, and ocular alignment, all contributed to the predictive model, which yielded a 73% correct classification rate in predicting future psychosis-spectrum disorders.

Non-neurological factors are also known to predate psychosis onset, and specific evidence for the influence of social risk factors is well-documented (Couture et al., 2006; Howes & Murray, 2014; Morgan et al., 2010). Tsuji et al. (2013), utilizing the same Mednick-led 50-year prospective dataset as Golembo-Smith et al. (2012), created a separate model in which childhood social functioning was identified as a significant predictor of adult psychosis-spectrum disorders (Tsuji et al., 2013).

The aim of the current study is to combine both premorbid neurological and social factors in a single, multivariate model. A combined model has the potential to inform how these variables interrelate, as well as to increase the accuracy of prediction over and above what any single variable could do alone (Shah et al., 2013).

Materials and Methods

Participants

This study recruited from the Copenhagen Perinatal Cohort, which included 9,125 individuals born between September 1, 1959 and December 31, 1961 at Rigshospitalet, Copenhagen, Denmark (Schiffman et al., 2009). In 1972, 265 “highrisk” participants (having a biological parent identified with schizophrenia) from the larger cohort were recruited for a more detailed evaluation. Matched controls were also recruited.

Recruitment, psychiatric evaluations, and social functioning assessments were orchestrated by researchers at the Institute of Preventive Medicine as well as the Rigshospitalet and University of Copenhagen. Participants received written informed consent. A complete recruitment and selection flowchart can be found in the online supplement to Golembo-Smith et al. (2012).

Assessment of genetic risk

Hospital record reviews and face-to-face interviews assessed parents’ psychiatric status in order to determine participant level of genetic risk. Three genetic risk groups were ascertained: children whose mother or father 1) had a psychiatric hospital diagnosis of schizophrenia (“high-risk”), 2) had a psychiatric hospitalization for a non-psychotic disorder (“other-risk”), and 3) had no record of psychiatric hospitalization (“low-risk”). Further validation of parental diagnoses were conducted in 1992 and 2007 (see Golembo-Smith et al., 2012). After attrition, the final risk groups were: high-risk, n = 94; other-risk, n = 84; and low-risk, n = 66. Final risk groups were relatively equivalent on demographic characteristics.

Measurements of neurological and social function

When participants were 10–13 years old, they were assessed by a pediatric neurologist on a variety of neurological tasks. Neurological variables included laterality, minor physical anomalies (MPAs), IQ, and coordination (Golembo-Smith et al., 2012). Concurrently, research participants’ teachers were asked to complete a fiveitem questionnaire assessing participants’ degree of social function within the school context (Tsuji et al., 2012). Table 1 provides a more detailed description of the neurodevelopmental and social variables.

Table 1.

Description of main neurological and social variables

Variable Measured Description of Measurement
Laterality Laterality was assessed during a detailed analysis of foot and eye dominance. Footedness was assessed by recording foot used (1=left, 0=right) when participant was asked to kick a ball, balance, and hop on one foot and then summing to yield a total footedness score. Total eye dominance scores were similarly calculated, by summing the individual scores (1=left, 0=right) from three eye preference tasks: Crider’s Ring, Crider’s Card, and Crider’s Box tasks (Crider, 1944). The total of both assessments were standardized and summed to form an overall laterality score, with higher scores indicating more left side preference (Schiffman et al., 2005).
MPA MPA examination was assessed using the Waldrop Scale and measures included: epicanthus, hyperteliorism, adherent ear lobes, low-seated ears, malformed ears, asymmetrical ears, soft pliable ears, single transverse palmar crease, high-steepled palate, third toe longer than second, partial syndactylia of two middle toes, fundus abnormalities, fine electric hair or two or more hair whorls, and furrowed tongue or tongue with smooth-rough spots (Waldrop and Halverson, 1971, Gottesman and Gould, 2003 and Compton and Walker, 2009). Each MPA was reported as present or absent, and summed, with higher scores indicating more MPAs (Schiffman et al., 2002).
IQ The Wechsler Intelligence Scale for Children (WISC) was used to measure verbal, performance, and full scale intelligence quotients with a mean of 100 and standard deviation of 15 (Weschler, 1949). Subscales included Similarities, Vocabulary, Block Design, and Maze. Each subscale provided a scaled score based on normative data with a mean of 10 and standard deviation of 3 (Sørensen et al., 2010).
Coordination Nine tests of coordination were used to create the coordination scale: right and left diadochokinesia, right and left finger opposition test, right and left index finger and right and left foot tap, and right hand-left hand opens-closes (Boks et al., 2000, and Rosso et al., 2000). Coordination scores were the sum of the standardized scores of coordination tests, with higher scores indicating more coordination dysfunction (Schiffman et al., 2009).
Social Function Completed by participants’ teachers, the social function scale is 5 questions selected and summed from within a larger 136-item questionnaire. The 5 functioning questions were recorded in Likert-type format with options between 1 and 5, yielding total scores between 5 and 25. Higher scores represented better social functioning (Tsuji et al. 2012).

Diagnostic outcome

In 1992, when participants were between the ages of 31 to 33, a psychiatrist administered the SCID (Spitzer et al., 1990) and the psychosis section of the Present State Examination (Wing et al., 1974). Participant psychiatric hospital records were also examined. In 2007, an additional diagnostic update was completed through a scan of the Danish Psychiatric Central Registry for psychiatric admissions between the years of 1994 to 2007. Adult diagnostic outcome data from the interviews and/or hospital records were available for 244 of the 265 initial subjects; 33 participants were diagnosed with a psychosis-spectrum disorder (“spectrum”), 78 were identified as having a non-psychotic disorder (“other disorder”), and 133 had no identified mental health diagnosis (“no mental illness”). (Table 2).

Table 2.

Primary diagnosis by age, sex, and genetic risk status of subjects

Age Mother’s
Age
Sex Genetic Risk Total

Mean SD Mean SD Male Female HR OR LR

Schizophrenia-spectrum
Schizophrenia 11.5 .77 27.5 7.7 10 8 15 2 1 18
Any psychosis or delusional disorder 11.7 .83 25.2 7.9 5 3 4 3 1 8
Schizotypal PD 11.6 .57 23.4 3.6 0 4 1 3 0 4
Paranoid PD 11.3 .61 25.2 3.2 0 2 2 0 0 2
Schizoid PD 10.5 n/a 38.6 n/a 1 0 0 0 1 1
Total Schizophrenia-spectrum 11.5 .74 26.6 7.3 16 17 22 8 3 33

Other Disorders
Non-psychotic mood or anxiety disorder 11.7 .63 24.2 5.5 12 15 12 11 4 27
Non-psychotic alcohol/drug abuse 11.9 .63 24.2 5.7 23 11 9 17 8 34
Non-spectrum personality disorders 11.7 .80 26.9 6.4 5 12 7 6 4 17
Total Other Disorders 11. .68 24.8 5.9 40 38 28 34 16 78

No mental illness
Total No Diagnosis 11.7 .64 27.4 6.9 64 69 44 42 47 133
All Participants 11.7 .67 26.4 6.7 120 124 94 84 66 244

Statistical Analyses

Missing data for the neurological measures were rare, however, 19% of the items completed by teachers were missing (see Tsuji et al., 2013). Data were missing completely at random (MCAR; χ2=29.17, df=19, p=.06) (Little, 1988). To maximize statistical power and address missing values, multiple imputations were implemented for the social variable (5 iterations, 50 case draws, 2 parameter draws, resulting in 5 imputations) (Rubin, 1987). Pooled estimates are reported.

The primary analysis was a multinomial logistic regression used to assess the predictive relation of neurological and social function variables collected premorbidly, and genetic risk, to diagnostic outcome. A secondary multinomial logistic regression with step-wise forward entry was performed to test the incremental contribution of the social function variable to the original neurodevelopmental model presented in Golembo-Smith et al. (2012). Utilizing the outcome from the primary regression model, a receiver operating characteristic (ROC) analysis was performed to determine a statistically derived “optimal” cut-off score using predictive probability of a psychosis-spectrum outcome. Analyses were conducted using SPSS 22.

Results

Table 3 reports ANOVAs between outcome groups. Significance and effect sizes (d) of between-group differences were examined using Bonferroni post-hoc comparison analysis (Table 4). A multinomial logistic regression predicting adult diagnostic outcomes from premorbid neurodevelopmental variables (sex, parental risk status, laterality, MPAs, ocular alignment, IQ scores, and coordination), as well as the social function variable, indicated that the model significantly predicted outcome diagnoses (spectrum, other diagnosis, or no mental illness; overall model χ2 (18,244) = 83.46, p < .01). Significant predictors in the full model included: parent diagnosis [χ2 = (2, 244) 12.48, p < .01]; MPAs [χ2 = (2, 244) 11.55, p < .01]; social function [χ2 = (2, 244) 29.76, p < .01]; and significance reaching trend status from IQ [χ2 = (2, 244) 5.72, p < .06].

Table 3.

Means, standard deviations, and F values of predictor variables

Variable Spectrum
Outcome

Mean (SD)
(Range)

N = 33

OD Outcome

Mean (SD)
(Range)

N = 78

NMI Outcome

Mean (SD)
(Range)

N = 133

F

p
Laterality 61 (1.63)
(−1.55 – 3.57)
.01 (1.53)
(−1.55 – 3.57)
−.16 (1.44)
(−1.55 – 3.57)
3.50 .03
MPA 3.50 (1.58)
(1 – 8)
2.73 (1.44)
(0 – 5)
2.57 (1.59)
(0 – 8)
4.79 .01
IQ 102.55 (17.96)
(45 – 130)
104.27 (15.11)
(69 – 147)
109.39 (13.85)
(66 – 151)
4.50 .01
Coordination 3.84 (8.35)
(−7.73 – 22.17)
.15 (6.07)
(−8.19 – 16.93)
−1.04 (6.02)
(−.7.96 – 19.51)
7.73 <.01
Social function 17.54 (4.92)
(6 – 25)
20.67 (3.36)
(9 – 25)
21.74 (2.96)
(8.10 – 25)
20.18 <.01

Note: OD=Other Disorders, NMI=No Mental Illness; higher scores indicate more dysfunction with the exception of the social function scale where lower scores indicates more dysfunction.

Table 4.

Post-hoc paired group comparisons

Variable Mean Difference
Effect Size
Spectrum – NMI Spectrum – OD OD – NMI
Laterality .77 (p=.009)
d=.50
.59 (p=.057)
d=.38
.17 (p=.415 )
d=.12
MPA .93 (p=.002)
d=.58
.77 (p=.017)
d=.51
.16 (p=.477)
d=.10
IQ −6.85 (p=.019)
d=.43
−1.72 (p =.577)
d=.10
−5.12 (p=.016)
d=.35
Coordination 4.88 (p< .001)
d=.67
3.70 (p=.006)
d=.51
1.19 (p=.195)
d=.20
Social function −4.20 (p< .001)
d=1.03
−3.13 (p<.001)
d=.74
−1.07 (p=.029)
d=.34

Note: OD=Other Disorders, NMI=No Mental Illness; d=Cohen’s d; α=.02 using Bonferroni correction

Follow-up multinomial logistic regression using step-wise forward entry methods in which neurological scales were included prior to adding the social function scale indicated that the addition of the social scale significantly improved the predicted fit of the model [χ2 change = (2, 244) 29.76, p < .01], and increased overall variance predicted [Cox and Snell R2 change = .092; Nagelkerke R2 change = .108]. Table 5 provides individual predictor information when predicting different outcomes.

Table 5.

Summary of multinomial logistic regression analysis

Group and predictor Wald x2 df B Odds Ratio p 95% CI
Spectrum vs. OD outcome
Intercept 1.49 1 3.27 .22
Parent w/ spectrum vs. NMI 4.1 1 −1.80 0.17 .04 .03–0.94
Parent w/ spectrum vs. OD 2.83 1 −0.93 0.40 .09 .13–1.16
Sex 0.99 1 −0.55 0.58 .32 .20–1.71
Laterality 1.04 1 −0.16 0.85 .31 .63–1.16
MPAs 7.76 1 −0.47 0.63 <.01 .45–0.87
Ocular Alignment 3.70 1 −0.22 0.81 .06 .65–1.00
IQ 0.87 1 −0.02 0.98 .35 .95–1.02
Coordination 2.49 1 −0.06 0.94 .11 .88–1.01
Social function 11.67 1 0.21 1.23 <.01 1.09–1.39

Spectrum vs. NMI outcome
Intercept 0.33 1 −1.58 .57
Parent w/ spectrum vs. NMI 7.89 1 −2.46 0.09 <.01 .02–0.48
Parent w/ spectrum vs. OD 1.50 1 −0.68 0.51 .22 .17–1.50
Sex 0.10 1 −0.17 0.84 .75 .29–2.45
Laterality 2.22 1 −0.24 0.79 .14 .58–1.08
MPAs 10.31 1 −0.53 0.59 <.01 .42-.81
Ocular Alignment 1.28 1 −0.11 0.90 .26 .74–1.09
IQ 0.41 1 0.01 1.01 .52 .98–1.05
Coordination 2.75 1 −0.06 0.94 .10 .87–1.01
Social function 23.91 1 0.32 1.37 <.01 1.21–1.56

Note: OD=Other Disorders, NMI=No Mental Illness

Model R2=.092 (Cox & Snell), .108 (Nagelkerke); Model x2 (18,244)=83.46, p<.001

Probabilistic diagnostic categorizations were predicted from the model, yielding 48.5% accuracy for those with a spectrum outcome and a total correct classification rate of 60.2% (Table 6). A ROC curve was plotted to predict spectrum versus non-spectrum outcomes (as ROC curves do not allow consideration of three outcomes, other disorders and no mental illness groups were combined). Using predicted probabilities as the ROC curve predictor variable, the AUC was .86 [95% C.I. = .78–.93, p < .01], in the “excellent” range (Hosmer & Lemeshow, 2000) (Fig 1).

Table 6.

Multinomial regression analysis classification summary

Predicted group membership
Observed Spectrum OD NMI Σ
Spectrum 16 2 15 33 (13.5%)
OD 7 18 53 78 (32.0%)
NMI 4 16 113 133 (54.5%)
Σ 27 (11.1%) 36 (14.8%) 181 (74.2%) 244 (100.0%)

Note: OD=Other Disorders, NMI=No Mental Illness

Figure 1.

Figure 1

ROC Curve predicting schizophrenia-spectrum vs. other outcomes

The “optimal” statistically derived cut-off was identified [see Golembo-Smith et al. (2012) for description on cut-off point calculations], yielding a sensitivity of .82, specificity of .76, positive predictive value of .35, and negative predictive value of .96. Overall, the inclusive model was able to correctly classify 77% of participants into spectrum vs. not-spectrum outcome groups (Table 7).

Table 7.

ROC analysis classification summary: spectrum vs. all others.

Predicted group membership
Observed Spectrum Not Spectrum Σ
Spectrum 27 6 33 (13.50%)
Not Spectrum 50 161 211 (86.50%)
Σ 77 (31.5%) 167(68.4%) 244 (100.0%)

Note: Not Spectrum = Other Disorders and No Mental Illness groups

Discussion

Extending our prior work predicting spectrum outcomes from premorbid neurological variables by including a measure of social function, the current study provides evidence for the complementary role of both factors. Results suggest social function is a unique and significant predictor, contributing independently to predicting diagnostic outcomes above and beyond that of the neurodevelopmental findings alone.

The pattern of findings remained for individual neurological predictors despite the inclusion of the social function variable. The multinomial logistic regression generated in the prior work yielded a correct classification rate of 33% for those with a psychosis outcome; in the current study, this increases to 48%. Although this increase is promising, it is also important to note that in both studies, the overall correct classification rate across the three outcome groups remained more or less constant at around 60%. This might imply that social functioning has special pertinence to psychosis-spectrum diagnoses as opposed to other outcomes. When examining the results from the ROC curve that maximized prediction between two groups (psychosis-spectrum versus all other participants), the correct classification rate of the updated model was 77%, with sensitivity of .76, and specificity of .821. Including the social function variable, the model correctly classified an additional three spectrum cases (now 27 out of 33), and two non-spectrum cases (now 161 out of 211), yielding a positive predictive value of .35.1

Recent efforts to predict psychosis have gravitated away from the more time intensive (nearly 50 year follow-up in this case) genetic dependent (parent with schizophrenia) high-risk model as employed in the current study, to a “clinical high-risk model” (CHR) that focuses more on identifying attenuated psychotic symptoms that tend to emerge one to two years prior to diagnosable psychosis. Clinical high-risk studies have shown promise in prediction of conversion to psychosis over two to three years (average two year conversion from risk to psychosis is 29%) (Fusar-Poli et al., 2012). Further, recent studies employing measures of biological (e.g., MRI, blood assays; Koutsouleris et al., 2009; Perkins et al., 2014) and social/environmental factors (e.g., urbanicity, social impairment; Dragt et al. 2011; Cannon et al., 2008) demonstrate the potential of using a variety of factors to improve overall accuracy of psychosis prediction models. Although there are many differences between CHR studies and the present study, the predictive ability of this nearly 50 year prospective study compares reasonably well with the more proximal CHR approach. The possibility of integrating early social and biological markers as seen in the present study, with other CHR factors currently emphasized in the field, has the potential to enhance the accuracy of early identification.

This study suffers from several notable limitations. Given the longitudinal nature of the study design, exact replication of these findings would be difficult. Nonetheless, the findings represent a “proof of concept,” suggesting that other prospective high-risk studies might be able to use both neurological and social premorbid measures to predict future onset of psychosis-spectrum disorders. It should also be noted that ROC analyses do not afford the opportunity to predict three groups, so our use of this analysis combined the “no mental illness” and “other disorder” groups together. Despite a loss of sensitivity to the distinctions between no mental illness and other non-psychotic illness, the ROC analysis does have real-world applicability for those interested in differentiating psychosis-spectrum from any other condition. Additionally, the social function scale had a large portion of missing data, and therefore we used multiple imputation to increase statistical power. It is relevant to note that the MCAR pattern suggested that the imputed values yielded unbiased statistical estimates, and unreported analyses using the raw data were very consistent with the imputed data.

Findings from this 50 year high-risk project could be considered within the context of a neurodevelopmental-social model, suggesting the inclusion of social risk factors as important, incrementally valid elements in a developmental trajectory towards psychosis (Howes & Murray, 2014). It is possible that early social difficulties and possible isolation from others, as measured here, may induce a stress response contributing to a cascade of exposure that leads to maladaptive biological responses (e.g., increased cortisol levels leading to dysregulation of dopaminergic pathways) that eventually contribute to psychosis (Mizrahi et al. 2012; Corcoran et al., 2003). This process, in conjunction with other neurologic pathways, may provide a more comprehensive account of a developmental course toward psychosis. These findings are in keeping with emerging evidence that there may be some, but not completely, overlapping underlying circuit dysfunction contributing to both neurological and social deficits (e.g., Gard et al., 2009; Wynn et al., 2010; Waltz and Gold, 2007). Additionally, a comprehensive premorbid screening evaluation that considers neurologically identified markers and social factors provides a useful illustration of the gradual unfolding of both physical and social signs of neurodevelopmental illness, and holds the potential to contribute to clinically useful prediction among people at genetic risk for psychosis.

Acknowledgment

This manuscript is dedicated to the memory of Sarnoff A. Mednick, a mentor of the highest quality, and a true visionary in this, and other, fields.

Role of Funding

This work was supported in part by funding from the Maryland Department of Health and Mental Hygiene, Behavioral Health Administration through the Center for Excellence on Early Intervention for Serious Mental Illness (OPASS# 14–13717G/M00B4400241).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Contributors

Dr. Schiffman oversaw the study design, data analysis, data interpretation, write-up, and manuscript preparation. Dr. Kline and Ms. Jameson contributed to analysis and write-up. Drs. Sorensen, Dodge, Mortensen, and Mr. Tsuji contributed to manuscript conceptualization, data-analysis consultation, and write-up. Dr. Sorensen also contributed to data collection. Dr. Mednick was the founder of this project, contributing to every aspect of the study.

Author Disclosure

The authors have no actual or potential conflicts of interest to disclose.

1

Golembo-Smith et al. (2012) correct classification was 75%, with sensitivity of .73 and specificity of .75.

References

  1. Boks MP, Russo S, Knegtering R, van den Bosch RJ. The specificity of neurological signs in schizophrenia: a review. Schizophrenia research. 2000;43(2):109–116. doi: 10.1016/s0920-9964(99)00145-0. [DOI] [PubMed] [Google Scholar]
  2. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28–37. doi: 10.1001/archgenpsychiatry.2007.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Compton MT, Walker EF. Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia? Schizophrenia Bulletin. 2009;35(2):425–436. doi: 10.1093/schbul/sbn151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corcoran C, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina D. The Stress Cascade and Schizophrenia: Etiology and Onset. Schizophrenia Bulletin. 2003;29(4):671–692. doi: 10.1093/oxfordjournals.schbul.a007038. [DOI] [PubMed] [Google Scholar]
  5. Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophrenia bulletin. 2006;32(suppl 1):S44–S63. doi: 10.1093/schbul/sbl029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crider B. A battery of tests for the dominant eye. The Journal of General Psychology. 1944;31(2):179–190. [Google Scholar]
  7. Dragt S, Nieman DH, Veltman D, Becker HE, van de Fliert R, de Haan L, Linszen DH. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk. Schizophrenia Research. 2011;125(1):69–76. doi: 10.1016/j.schres.2010.09.007. [DOI] [PubMed] [Google Scholar]
  8. Erlenmeyer-Kimling L, Rock D, Roberts SA, Janal M, Kestenbaum C, Cornblatt B, Gottesman II. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry. 2000;157(9):1416–1422. doi: 10.1176/appi.ajp.157.9.1416. [DOI] [PubMed] [Google Scholar]
  9. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69(3):220–229. doi: 10.1001/archgenpsychiatry.2011.1472. [DOI] [PubMed] [Google Scholar]
  10. Gard DE, Fisher M, Garrett C, Genevsky A, Vinogradov S. Motivation and its Relationship to Neurocognition, Social Cognition, and Functional Outcome in Schizophrenia. Schizophrenia Research. 2009;115(1):74–81. doi: 10.1016/j.schres.2009.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Golembo-Smith S, Schiffman J, Kline E, Sorensen HJ, Mortensen EL, Stapleton L, Mednick S. Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizophrenia-spectrum disorder: a high-risk prospective investigation. Schizophrenia Research. 2012;139(1–3):129–135. doi: 10.1016/j.schres.2012.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry. 2003;160(4):636–645. doi: 10.1176/appi.ajp.160.4.636. [DOI] [PubMed] [Google Scholar]
  13. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: WileyJames, LR; 2000. [Google Scholar]
  14. Howes OD, Murray RM. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet. 2014;383(9929):1677–1687. doi: 10.1016/S0140-6736(13)62036-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Isohanni M, Lauronen E, Moilanen K, Isohanni I, Kemppainen L, Koponen H, Murray GK. Predictors of schizophrenia: evidence from the Northern Finland 1966 Birth Cohort and other sources. Br J Psychiatry Suppl. 2005;48:s4–s7. doi: 10.1192/bjp.187.48.s4. [DOI] [PubMed] [Google Scholar]
  16. Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Gaser C. Use of Neuroanatomical Pattern Classification to Identify Subjects in At-Risk Mental States of Psychosis and Predict Disease Transition. Arch Gen Psychiatry. 2009;66(7):700–712. doi: 10.1001/archgenpsychiatry.2009.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Koutsouleris N, Riecher-Rössler A, Meisenzahl EM, Smieskova R, Studerus E, Kambeitz-Ilankovic L, Borgwardt S. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophrenia bulletin. 2014;41(2):471–482. doi: 10.1093/schbul/sbu078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Little RJA. A test of missing completely at random for multivariate data with missing values. J. Am. Stat. Assoc. 1988;83(404):1198–1202. [Google Scholar]
  19. Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Wilson AA. Increased Stress-Induced Dopamine Release in Psychosis. Biological Psychiatry. 2012;71(6):561–567. doi: 10.1016/j.biopsych.2011.10.009. [DOI] [PubMed] [Google Scholar]
  20. Morgan C, Charalambides M, Hutchinson G, Murray RM. Migration, ethnicity, and psychosis: toward a sociodevelopmental model. Schizophrenia Bulletin. 2010;36(4):655–664. doi: 10.1093/schbul/sbq051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R. Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project. Schizophrenia Bulletin. 2014;41(2):419–428. doi: 10.1093/schbul/sbu099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rosso IM, Bearden CE, Hollister JM, Gasperoni TL, Sanchez LE, Hadley T, Cannon TD. Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophrenia Bulletin. 2000;26(2):367. doi: 10.1093/oxfordjournals.schbul.a033459. [DOI] [PubMed] [Google Scholar]
  23. Rubin DB. Multiple Imputation for Nonresponse Surveys. New York: John Riley & Sons, Inc.; 1987. [Google Scholar]
  24. Schiffman J, Ekstrom M, LaBrie J, Schulsinger F, Sørensen H, Mednick S. Minor physical anomalies and schizophrenia spectrum disorders: A prospective investigation. Am. J. Psychiatry. 2002;159(2):238–243. doi: 10.1176/appi.ajp.159.2.238. [DOI] [PubMed] [Google Scholar]
  25. Schiffman J, Maeda JA, Hayashi K, Michelsen N, Sørensen HJ, Ekstrom M, et al. Premorbid childhood ocular alignment abnormalities and adult schizophrenia-spectrum disorder. Schizophr. Res. 2006;81(2–3):253–260. doi: 10.1016/j.schres.2005.08.008. [DOI] [PubMed] [Google Scholar]
  26. Schiffman J, Pestle S, Mednick S, Ekstrom M, Sørensen H, Mednick S. Childhood laterality and adult schizophrenia spectrum disorders: A prospective investigation. Schizophr. Res. 2005;72(2–3):151–160. doi: 10.1016/j.schres.2004.04.003. [DOI] [PubMed] [Google Scholar]
  27. Schiffman J, Sorensen HJ, Maeda J, Mortensen EL, Victoroff J, Hayashi K, Mednick S. Childhood motor coordination and adult schizophrenia spectrum disorders. American Journal of Psychiatry. 2009;166(9):1041–1047. doi: 10.1176/appi.ajp.2009.08091400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sørensen HJ, Mortensen EL, Schiffman J, Ekstrøm M, Denenny D, Mednick SA. Premorbid IQ and adult schizophrenia spectrum disorder: Verbal and performance subtests. Psychiat. Res. 2010;178:23–26. doi: 10.1016/j.psychres.2010.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shah JL, Tandon N, Keshavan MS. Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention. Early Intervention in Psychiatry. 2013;7(4):345–360. doi: 10.1111/eip.12054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Spitzer RL, Williams JB, Gibbon M, First MB. User's guide for the structured clinical interview for DSM-III-R: SCID: American Psychiatric Association. 1990. [Google Scholar]
  31. Tsuji T, Kline E, Sørensen HJ, Mortensen EL, Michelsen NM, Ekstrom M, Schiffman J. Premorbid teacher-rated social functioning predicts adult schizophrenia-spectrum disorder: A high-risk prospective investigation. Schizophrenia Research. 2013;151(1–3):270–273. doi: 10.1016/j.schres.2013.10.022. [DOI] [PubMed] [Google Scholar]
  32. Waldrop MF, Halverson CF. Minor physical anomalies and hyperactive behavior in young children. The Exceptional Infant. 1971;2:343–380. [Google Scholar]
  33. Walker E, Shapiro D, Esterberg M, Trotman H. Neurodevelopment and Schizophrenia: Broadening the Focus. Current Directions in Psychological Science. 2010;19(4):204–208. [Google Scholar]
  34. Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res. 2007;93(1–3):296–303. doi: 10.1016/j.schres.2007.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wechsler D. Manual for the Wechsler intelligence scale for children, revised. Psychological Corporation; 1974. [Google Scholar]
  36. Wing J, Cooper J, Sartorius N. The measurement and classification of psychiatric symptoms: an instruction manual for the Present State Examination and CATEGO program. Oxford, England: Cambridge University Press; 1974. [Google Scholar]

RESOURCES